DSE/ASIAPACINS (DSE/ASIAPACINS)

Dhaka Stock Exchange: DSE/ASIAPACINS · BDT

BDT 44.1

+0.90 (+2.1%)· Recorded snapshot

Market cap	1.9B
Revenue (ttm)	629M
Net income (ttm)	119.2M
EPS (ttm)	BDT 2.81
Shares out	42.4M
P/E (trailing)	15.7x
Dividend	BDT 1.40 (3.17%)
Volume	64,602
Beta	0.50

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 629M
Net income (ttm): 119.2M
EPS (ttm): BDT 2.81
P/E (trailing): 15.7x
Market cap: 1.9B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E15.7

P25 n/aP50 n/aP75 n/a

ROE10.6

P25 n/aP50 n/aP75 n/a

ROIC10.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All DSE/ASIAPACINS indicators

Market & fundamental data

Available fields

224

Groups with data

Currency

BDT

Showing 224 of 224 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BDT
Country	Bangladesh
Country code	BD
Earnings date	2026-11-03
Employees	569
Employees change	352
Employees growth	162.21%
Enterprise value	BDT 904.8M
Exchange	Dhaka Stock Exchange
Financial currency	BDT
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1999
Industry	Insurance Carriers
Is primary listing	Yes
ISIN number	BD0728APGI04
Last earnings date	2026-07-29
Last refreshed	2026-10-29
Last stock split date	2011-12-04
Last stock split type	Forward
Market cap	BDT 1.9B
Next earnings date	2026-11-03
Price	BDT 44.10
Price currency	BDT
SIC code	6300
Stock price date	2026-10-28
Symbol	dse/ASIAPACINS
Website	https://www.apgicl.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	18.35x
Average P/E ratio (3Y)	18.69x
Average P/E ratio (5Y)	20.12x
Earnings yield	6.38%
EV/Earnings	7.59x
EV/EBIT	5.53x
EV/EBITDA	5.09x
EV/FCF	5.64x
EV/Sales	1.44x
FCF / EV yield	17.74%
FCF yield	8.6%
Graham number	41.72309
Graham upside	-5.39%
Lynch fair value	BDT 14.07
Lynch upside	-68.09%
P/B ratio	1.6x
P/E ratio	15.67x
P/FCF ratio	11.63x
P/OCF ratio	10.65x
P/S ratio	2.97x
Price / tangible book value	1.6x
Price/EBITDA ratio	10.51x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	26%
EBITDA margin	28.24%
Effective tax rate	26.5%
FCF margin	25.52%
Gross margin	72.01%
Operating margin	26%
Pretax margin	25.78%
Profit margin	18.95%
Profit per employee	BDT 209,464
Revenue per employee	BDT 1.1M
ROA	5.84%
ROA (5Y)	5.78%
ROCE	14.05%
ROE	10.59%
ROE (5Y)	9.79%
ROIC	10.52%
ROIC (5Y)	9.9%
Tax / revenue	6.83%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	70.45%
EPS growth (Q)	19.77%
EPS growth (QoQ)	-11.4%
EPS growth 10Y	6.98%
EPS growth 3Y	5.69%
EPS growth 5Y	3.03%
FCF growth (QoQ)	153.37%
FCF growth 3Y	21.19%
FCF growth 5Y	6.57%
Net income growth	70.45%
Net income growth (Q)	20.55%
Net income growth (QoQ)	-11.21%
Net income growth 3Y	5.68%
Net income growth 5Y	2.95%
OCF growth	1,311.17%
OCF growth (QoQ)	152.58%
OCF growth 10Y	7.61%
OCF growth 3Y	24.43%
OCF growth 5Y	7.79%
Revenue growth	41.15%
Revenue growth (Q)	-13.36%
Revenue growth (QoQ)	12.8%
Revenue growth 10Y	9.11%
Revenue growth 3Y	11.21%
Revenue growth 5Y	12.09%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BDT -14.9M
EBIT	BDT 163.6M
EBITDA	BDT 177.7M
EPS	BDT 2.81
FCF per share	BDT 3.79
Financing cash flow	BDT -39.2M
Free cash flow	BDT 160.5M
Gross profit	BDT 452.9M
Income taxes	BDT 43M
Investing cash flow	BDT -21.8M
Net cash flow	BDT 114.4M
Net income	BDT 119.2M
Operating income	BDT 163.6M
Revenue	BDT 629M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	BDT 27.49
Debt / equity	0
Net cash (debt)	BDT 962.8M
Net cash / market cap	51.55%
Net cash growth	14.43%
Net debt / EBITDA	-5.42
Net debt / equity	-0.83
Net debt / FCF	-6
Piotroski F-Score	5
Property, plant and equipment	BDT 145.8M
Shareholders' equity	BDT 1.2B
Tangible book value	BDT 1.2B
Tangible book value per share	BDT 27.49
Total assets	BDT 1.9B
Total cash	BDT 1B
Total debt	BDT 0
Total liabilities	BDT 705.4M
WACC	6.98%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.36
Current ratio	2.44
Net working capital	BDT 55.7M
Quick ratio	1.76
Working capital	BDT 1B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend growth	40%
Dividend growth (10Y)	3.42%
Dividend growth (3Y)	-2.27%
Dividend growth (5Y)	6.96%
Dividend growth years	0
Dividend payment date	2026-08-09
Dividend payment years	16
Dividend payout frequency	Annual
Dividend per share	BDT 1.40
Dividend yield	3.18%
Ex-dividend date	2026-05-23
FCF payout ratio	36.94%
Last dividend	BDT 1.40
Payout ratio	32.91%
Shareholder yield	3.18%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	170%
10Y return CAGR	14.72%
10Y total return	294.77%
150-day SMA	BDT 44.50
15Y price change	8.48%
15Y return CAGR	4.83%
15Y total return	102.9%
1D price change	2.08%
1M price change	-9.24%
1M total return	-9.24%
1W price change	-3.79%
1W total return	-3.79%
1Y price change	27.43%
1Y return CAGR	31.75%
1Y total return	31.72%
20-day SMA	BDT 45.74
200-day SMA	BDT 42.25
20Y price change	877.15%
20Y return CAGR	19.78%
20Y total return	3,598.31%
3M price change	-1.59%
3M total return	-1.59%
3Y price change	-18.34%
3Y return CAGR	-3.44%
3Y total return	-9.97%
50-day SMA	BDT 47.59
50-day SMA vs 200-day SMA	50over200
52-week high	BDT 55.70
52-week high date	2026-08-06
52-week low	BDT 27.70
52-week low date	2025-11-16
5Y price change	-37.3%
5Y return CAGR	-5.87%
5Y total return	-26.09%
6M price change	9.37%
6M total return	13.05%
All-time high	BDT 124.90
All-time high date	2010-11-29
All-time low	BDT 3.47
All-time low date	2006-07-10
Average true range (ATR)	BDT 1.57
Average volume	75.6K
Beta (1Y)	0.65
Beta (2Y)	0.3
Beta (5Y)	0.5
Change from 52-week high	-20.83%
Change from 52-week low	59.21%
Change from all-time high	-65.41%
Change from all-time low	1,144.6%
Change from open	0.92%
Day's gap	1.16%
Dollar volume	BDT 2.8M
High price	BDT 44.40
Low price	BDT 43.50
Monthly RSI	55.32
Open price	BDT 43.70
Position in 52-week range	66.67%
Previous close	BDT 43.20
Price vs 150-day SMA	-2.92%
Price vs 20-day SMA	-5.54%
Price vs 200-day SMA	2.24%
Price vs 50-day SMA	-9.22%
Relative volume	0.85
RSI	40.33
Sharpe ratio	0.64
Sharpe ratio (3Y)	0
Sharpe ratio (5Y)	-0.05
Sortino ratio	1.2
Sortino ratio (3Y)	0.16
Sortino ratio (5Y)	0.08
Volume	64.6K
Weekly RSI	0
YTD price change	41.64%
YTD total return	46.41%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	28.1M
Shares change (QoQ)	0.22%
Shares held by insiders	33.61%
Shares outstanding	42.4M

Deeper analysis on DSE/ASIAPACINS

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this DSE/ASIAPACINS report

Is a complete DSE/ASIAPACINS research report available?

No complete published report is available for dse/ASIAPACINS (DSE/ASIAPACINS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

DSE/ASIAPACINS (DSE/ASIAPACINS)

Price

Financial snapshot

Fair-value bridge

Latest news · DSE/ASIAPACINS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All DSE/ASIAPACINS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on DSE/ASIAPACINS

Frequently asked questions